Generics

Filter

Current filters:

None

Popular Filters

82 to 106 of 1223 results

European and Japanese generics groups view opportunities on biosimilars

European and Japanese generics groups view opportunities on biosimilars

29-05-2014

The European Generic Medicines Association (EGA) participated in several meetings with Japanese government…

BiosimilarsEuropeGenericsJapanMarkets & MarketingRegulation

Hikma to buy Boehringer’s Bedford Labs unit for $300 million

Hikma to buy Boehringer’s Bedford Labs unit for $300 million

28-05-2014

Jordon-based drugmaker Hikma Pharmaceuticals has signed an asset purchase agreement with Ben Venue Laboratories,…

Bedford LaboratoriesBoehringer IngelheimGenericsHikma PharmaceuticalsMergers & AcquisitionsUSA

Actavis challenges AstraZeneca’s diabetes drug Onglyza patent in the USA

Actavis challenges AstraZeneca’s diabetes drug Onglyza patent in the USA

28-05-2014

Generics major Actavis yesterday confirmed that it has filed an Abbreviated New Drug Application with…

ActavisAstraZenecaDiabetesGenericsOnglyzaPatentsUSA

Recordati finalizes second tranche of Opalia Pharma acquisition

27-05-2014

Following previous announcements about its M&A activity, Italian drugmaker Recordati has now announced…

GenericsMergers & AcquisitionsOpalia PharmaRecordatiRest of the World

Congressional hearing in Brazil will discuss the efficacy of generic medicines

26-05-2014

The Brazilian Commission for Consumer Protection will soon hold a hearing to discuss the effectiveness…

BrazilGenericsPoliticsRegulation

Indian court ruling lifts temporary stay on Sun Pharma takeover of Ranbaxy

26-05-2014

Indian generics drugmaker Sun Pharmaceuticals’ proposed $3.2 billion acquisition of loss-making rival…

Daiichi SankyoGenericsLegalMergers & AcquisitionsRanbaxy LaboratoriesSun Pharmaceuticals

Prasco to market authorized generic of NeoProfen Injection

22-05-2014

Privately held US generic drugmaker Prasco Laboratories has entered into a distribution and supply agreement…

GenericsLicensingNeoProfenNeurologicalPrasco LaboratoriesRecordatiUSA

Russian PM visits country's first commercial manufacturing plant for MAb-based therapeutic proteins

20-05-2014

Russian Prime Minister Dmitri Medvedev on Monday visited the commercial manufacturing facility for monoclonal…

BiocadBiosimilarsGenericsOncologyProductionRussia

Abbott spends $2.9 billion on CFR Pharma to expand Latin American presence

16-05-2014

US drugmaker Abbott has signed an agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals,…

Abbott LaboratoriesCFR PharmaceuticalsGenericsMergers & AcquisitionsSouth America

Lilly loses out in UK Alimta vitamin dosage regimen patent law suit

16-05-2014

US pharma major Eli Lilly says that the English High Court has determined that the vitamin dosage regimen…

ActavisAlimtaEli LillyGenericsLegalOncologyPatentsUK

Generic drugs will be a key element of Mexico's health care modernization; report

16-05-2014

Although Mexico has made great efforts to improve its regulatory framework and create a more hospitable…

GenericsHealthcareMarkets & MarketingMexico

US Court rejects Teva’s Copaxone appeal

15-05-2014

A US district court has dismissed a case by Israeli drugmaker Teva Pharmaceutical Industries intended…

CopaxoneGenericsLegalMylanNeurologicalPatentsTeva Pharmaceutical IndustriesUSA

Novartis patent settlement on Gleevec with Sun Pharma subsidiary

15-05-2014

The US unit of Swiss drug major Novartis has settled its litigation with the US subsidiary of India’s…

GenericsGleevecNovartisOncologyPatentsSun Pharmaceutical IndustriesUSA

Biocad’s AcellBia is first MAb biosimilar approved by Russia’s Ministry of Health

15-05-2014

A biosimilar of Swiss drug major Roche’s MabThera (rituximab), to be marketed under the trade name…

AcellBiaBiocadBiosimilarsGenericsMabTheraOncologyRegulationRocheRussia

Novasep commissions 4 million-euro plant extension for commercial ADC payload manufacturing

15-05-2014

French ingredients company Novasep says that its 4 million-euro ($5.5 million) investment to expand its…

FranceGenericsNovasepOncologyProduction

Mylan debuts generic Zyprexa Zydis in USA; Actavis Exalgo copy approved

Mylan debuts generic Zyprexa Zydis in USA; Actavis Exalgo copy approved

14-05-2014

US generic drugmaker Mylan says it has launched Olanzapine Orally Disintegrating tablets (ODT), 5mg,…

ActavisEli LillyExalgoGenericsMallinckrodtMarkets & MarketingMylanNeurologicalRegulationUSAZyprexa

Fresenius Kabi expands IV drug business in Latin America with buy of Novafarma

Fresenius Kabi expands IV drug business in Latin America with buy of Novafarma

13-05-2014

Germany-based Fresenius Kabi has entered into an agreement to acquire the privately held Brazilian pharmaceutical…

BrazilFresenius KabiGenericsMergers & AcquisitionsNovafarma Industria Farmaceutica

Akorn to acquire VersaPharm for $440 million

Akorn to acquire VersaPharm for $440 million

10-05-2014

Following swiftly on its completion of the acquisition of Hi-Tech Pharmacal (Nasdaq: HITK) for $640 million…

AkornDermatologicalsGenericsMergers & AcquisitionsVersaPharm

Vivus says Actavis has filed ANDA for generic Qsymia

Vivus says Actavis has filed ANDA for generic Qsymia

10-05-2014

US drug developer Vivus disclosed on Friday that the company had received notice from generics major…

ActavisGenericsMetabolicsPatentsQsymiaRegulationUSAVivus

Actavis debuts generic copy of Catapres-TTS

Actavis debuts generic copy of Catapres-TTS

08-05-2014

Ireland-headquartered generics major Actavis has launched a generic version of German family-owned pharma…

ActavisBoehringer IngelheimCardio-vascularCatapres-TTSGenericsMarkets & MarketingUSA

Grunenthal strengthens pain product portfolio with European rights to etoricoxib

07-05-2014

Family-owned German drugmaker Grunenthal Group today announced the signing of an exclusive promotion…

etoricoxibEuropeGenericsGrunenthalLicensingMerck & CoNeurological

Australian Audit Commission’s “nuclear option to attack the PBS is madness”

Australian Audit Commission’s “nuclear option to attack the PBS is madness”

05-05-2014

The Australian National Commission of Audit’s complete dismantling and destruction of the Pharmaceutical…

AustraliaFinancialGenericsHealthcarePolitics

82 to 106 of 1223 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top